(Q35748053)

10 August 2017

title

Bcl-2 expression inhibits liver carcinogenesis and delays the development of proliferating foci (English)

1 reference

10 August 2017

1 reference

Robert H Pierce

1

1 reference

10 August 2017

Mary E Vail

2

1 reference

10 August 2017

Leah Ralph

3

1 reference

10 August 2017

Jean S Campbell

4

1 reference

10 August 2017

Nelson Fausto

5

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

The American Journal of Pathology

10 August 2017

published in

1 reference

10 August 2017

volume

160

1 reference

10 August 2017

issue

5

1 reference

10 August 2017

page(s)

1555-1560

1 reference

Bcl-2 retards cell cycle entry through p27(Kip1), pRB relative p130, and altered E2F regulation

10 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850870

Prognostic value of bcl-2 oncoprotein expression in stage II colon carcinoma

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850870

The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850870

The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850870

Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850870

Apoptosis and multistage carcinogenesis in rat liver

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850870

Rapid development of hepatic tumors in transforming growth factor alpha transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbital

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850870

Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850870

Bcl-2: an antidote to programmed cell death

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850870

Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor alpha.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850870

Quantitative analysis of tumor initiation in rat liver: role of cell replication and cell death (apoptosis).

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850870

Bcl-2 expression delays mammary tumor development in dimethylbenz(a)anthracene-treated transgenic mice.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850870

Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regression.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850870

Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850870

High, persistent hepatocellular proliferation and apoptosis precede hepatocarcinogenesis in growth hormone transgenic mice

25 September 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2961101-7

Bcl-2 expression delays hepatocyte cell cycle progression during liver regeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2961101-7

Loss of anti-mitotic effects of Bcl-2 with retention of anti-apoptotic activity during tumor progression in a mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2961101-7

p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2961101-7

Inverse correlation between bcl-2 expression and cell growth fraction in human endometrial adenocarcinoma tissue

7 January 2021

1 reference

12 December 2020

BCL-2 expression correlates with lower proliferative activity in the intermediate- and high-grade non-Hodgkin's lymphomas: an Eastern Cooperative Oncology Group and Southwest Oncology Group cooperative laboratory study

1 reference

12 December 2020

Paradoxical inhibition of c-myc-induced carcinogenesis by Bcl-2 in transgenic mice

1 reference

12 December 2020

Collaboration between growth factors and diverse chemical carcinogens in hepatocarcinogenesis of transforming growth factor alpha transgenic mice

1 reference

12 December 2020

10.1016/S0002-9440(10)61101-7

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

1 reference